Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bärmeier

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pediatric Pulmonology|October 12, 2001
Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agentsJ Rosenecker, I Eichler, H Bärmeier, et al.
Chronobiology International|January 1, 1987
On the daily variation in the beta-receptor-adenylate cyclase-cAMP-phosphodiesterase system in rat forebrainB Lemmer, H Bärmeier, S Schmidt, et al.
Endocrinology and Metabolism Clinics of North America|September 1, 1991
Autoimmunity of diabetesA Lernmark, H Bärmeier, S Dube, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 9, 2005
Prospective evaluation of emerging bacteria in cystic fibrosisG Steinkamp, B Wiedemann, E Rietschel, et al.
Autoimmunity|January 1, 1992
Quantitative analysis of islet glutamic acid decarboxylase p64 autoantibodies in insulin-dependent diabetes mellitusH Bärmeier, J Ahlmén, M Landin-Olsson, et al.
Infection|July 8, 2000
Optimal tobramycin dosage in patients with cystic fibrosis--evidence for predictability based on previous drug monitoringK Bartel, T Habash, S Lugauer, et al.
Diabetologia|October 1, 1991
Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodiesH Bärmeier, D K McCulloch, J L Neifing, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10A E Karlsen, W A Hagopian, C E Grubin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pediatric Pulmonology|October 12, 2001
Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agentsJ Rosenecker, I Eichler, H Bärmeier, et al.
Chronobiology International|January 1, 1987
On the daily variation in the beta-receptor-adenylate cyclase-cAMP-phosphodiesterase system in rat forebrainB Lemmer, H Bärmeier, S Schmidt, et al.
Endocrinology and Metabolism Clinics of North America|September 1, 1991
Autoimmunity of diabetesA Lernmark, H Bärmeier, S Dube, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 9, 2005
Prospective evaluation of emerging bacteria in cystic fibrosisG Steinkamp, B Wiedemann, E Rietschel, et al.
Autoimmunity|January 1, 1992
Quantitative analysis of islet glutamic acid decarboxylase p64 autoantibodies in insulin-dependent diabetes mellitusH Bärmeier, J Ahlmén, M Landin-Olsson, et al.
Infection|July 8, 2000
Optimal tobramycin dosage in patients with cystic fibrosis--evidence for predictability based on previous drug monitoringK Bartel, T Habash, S Lugauer, et al.
Diabetologia|October 1, 1991
Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodiesH Bärmeier, D K McCulloch, J L Neifing, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10A E Karlsen, W A Hagopian, C E Grubin, et al.
Pageof 1